Company news

Correvio Pharma Corp news in 2015

Correvio Pharma Corp's news releases, calls and decks from 2015, newest first.

View company

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

December 22, 2015

Cardiome Reports Third Quarter 2015 Financial Results

November 13, 2015

Cardiome to Hold Third Quarter 2015 Financial Results Conference Call on November 13

November 6, 2015

Cardiome announces addition of Robert James Meyer, M.D. to board of directors

September 8, 2015

Cardiome to Present at the 17th Annual Rodman & Renshaw Global Investment Conference

August 27, 2015

Cardiome Expands Partnership with Eddingpharm to Commercialize AGGRASTAT in China

August 24, 2015

United Kingdom Department of Health Sets BRINAVESS Pricing

August 10, 2015

Cardiome Reports Second Quarter 2015 Financial Results

August 5, 2015

Cardiome to Hold Second Quarter 2015 Financial Results Conference Call on August 5

July 28, 2015

Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China

July 24, 2015

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

Cardiome to Present at JMP Securities Healthcare Conference

June 16, 2015

Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation

June 12, 2015

Cardiome Appoints David Dean Vice President, Business Development and Investor Relations

June 3, 2015

Cardiome Reports First Quarter 2015 Financial Results

May 13, 2015

Cardiome and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreement

May 12, 2015

Cardiome To Hold First Quarter 2015 Financial Results Conference Call On May 13

May 7, 2015

Cardiome to Present at Bloom Burton & Co. Healthcare Investor Conference

April 27, 2015

Cardiome Receives BRINAVESS Reimbursement Approval From Belgian Authorities

April 9, 2015

Cardiome reports fourth quarter and full year 2014 financial results

March 12, 2015

Cardiome to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on March 12

March 5, 2015